139 related articles for article (PubMed ID: 25788127)
1. Rational drug design applied to myeloperoxidase inhibition.
Van Antwerpen P; Zouaoui Boudjeltia K
Free Radic Res; 2015 Jun; 49(6):711-20. PubMed ID: 25788127
[TBL] [Abstract][Full Text] [Related]
2. Mapping myeloperoxidase to identify its promiscuity properties using docking and molecular dynamics simulations.
Ramírez-Durán LA; Rosales-Hernández MC; Hernández-Rodríguez M; Mendieta-Wejebe JE; Trujillo-Ferrara J; Correa-Basurto J
Curr Pharm Des; 2013; 19(12):2204-15. PubMed ID: 23016839
[TBL] [Abstract][Full Text] [Related]
3. Novel bis-arylalkylamines as myeloperoxidase inhibitors: Design, synthesis, and structure-activity relationship study.
Aldib I; Gelbcke M; Soubhye J; Prévost M; Furtmüller PG; Obinger C; Elfving B; Alard IC; Roos G; Delporte C; Berger G; Dufour D; Zouaoui Boudjeltia K; Nève J; Dufrasne F; Van Antwerpen P
Eur J Med Chem; 2016 Nov; 123():746-762. PubMed ID: 27537923
[TBL] [Abstract][Full Text] [Related]
4. Characterization of chemical features of potent myeloperoxidase inhibitors.
Soubhye J; Meyer F; Furtmüller P; Obinger C; Dufrasne F; Antwerpen PV
Future Med Chem; 2016 Jul; 8(11):1163-77. PubMed ID: 27402298
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of new scaffolds of myeloperoxidase inhibitors by rational design combined with high-throughput virtual screening.
Aldib I; Soubhye J; Zouaoui Boudjeltia K; Vanhaeverbeek M; Rousseau A; Furtmüller PG; Obinger C; Dufrasne F; Nève J; Van Antwerpen P; Prévost M
J Med Chem; 2012 Aug; 55(16):7208-18. PubMed ID: 22793255
[TBL] [Abstract][Full Text] [Related]
6. Myeloperoxidase: a target for new drug development?
Malle E; Furtmüller PG; Sattler W; Obinger C
Br J Pharmacol; 2007 Nov; 152(6):838-54. PubMed ID: 17592500
[TBL] [Abstract][Full Text] [Related]
7. The development of myeloperoxidase inhibitors.
Galijasevic S
Bioorg Med Chem Lett; 2019 Jan; 29(1):1-7. PubMed ID: 30466896
[TBL] [Abstract][Full Text] [Related]
8. Conception of myeloperoxidase inhibitors derived from flufenamic acid by computational docking and structure modification.
Van Antwerpen P; Prévost M; Zouaoui-Boudjeltia K; Babar S; Legssyer I; Moreau P; Moguilevsky N; Vanhaeverbeek M; Ducobu J; Nève J; Dufrasne F
Bioorg Med Chem; 2008 Feb; 16(4):1702-20. PubMed ID: 18063373
[TBL] [Abstract][Full Text] [Related]
9. Discovery and structure activity relationships of 7-benzyl triazolopyridines as stable, selective, and reversible inhibitors of myeloperoxidase.
Shaw SA; Vokits BP; Dilger AK; Viet A; Clark CG; Abell LM; Locke GA; Duke G; Kopcho LM; Dongre A; Gao J; Krishnakumar A; Jusuf S; Khan J; Spronk SA; Basso MD; Zhao L; Cantor GH; Onorato JM; Wexler RR; Duclos F; Kick EK
Bioorg Med Chem; 2020 Nov; 28(22):115723. PubMed ID: 33007547
[TBL] [Abstract][Full Text] [Related]
10. Myeloperoxidase Inhibitors as Potential Drugs.
Lazarević-Pasti T; Leskovac A; Vasić V
Curr Drug Metab; 2015; 16(3):168-90. PubMed ID: 26279325
[TBL] [Abstract][Full Text] [Related]
11. Synthetic Guaiacol Derivatives as Promising Myeloperoxidase Inhibitors Targeting Atherosclerotic Cardiovascular Disease.
Premkumar J; Sampath P; Sanjay R; Chandrakala A; Rajagopal D
ChemMedChem; 2020 Jul; 15(13):1187-1199. PubMed ID: 32368837
[TBL] [Abstract][Full Text] [Related]
12. Small molecule and macrocyclic pyrazole derived inhibitors of myeloperoxidase (MPO).
Hu CH; Neissel Valente MW; Halpern OS; Jusuf S; Khan JA; Locke GA; Duke GJ; Liu X; Duclos FJ; Wexler RR; Kick EK; Smallheer JM
Bioorg Med Chem Lett; 2021 Jun; 42():128010. PubMed ID: 33811992
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the mechanism by which tryptophan analogs inhibit human myeloperoxidase.
Sliskovic I; Abdulhamid I; Sharma M; Abu-Soud HM
Free Radic Biol Med; 2009 Oct; 47(7):1005-13. PubMed ID: 19596067
[TBL] [Abstract][Full Text] [Related]
14. Mechanistic characterization of a 2-thioxanthine myeloperoxidase inhibitor and selectivity assessment utilizing click chemistry--activity-based protein profiling.
Ward J; Spath SN; Pabst B; Carpino PA; Ruggeri RB; Xing G; Speers AE; Cravatt BF; Ahn K
Biochemistry; 2013 Dec; 52(51):9187-201. PubMed ID: 24320749
[TBL] [Abstract][Full Text] [Related]
15. Flavonoids as substrates and inhibitors of myeloperoxidase: molecular actions of aglycone and metabolites.
Shiba Y; Kinoshita T; Chuman H; Taketani Y; Takeda E; Kato Y; Naito M; Kawabata K; Ishisaka A; Terao J; Kawai Y
Chem Res Toxicol; 2008 Aug; 21(8):1600-9. PubMed ID: 18620432
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of myeloperoxidase activity by the alkaloids of Peganum harmala L. (Zygophyllaceae).
Bensalem S; Soubhye J; Aldib I; Bournine L; Nguyen AT; Vanhaeverbeek M; Rousseau A; Boudjeltia KZ; Sarakbi A; Kauffmann JM; Nève J; Prévost M; Stévigny C; Maiza-Benabdesselam F; Bedjou F; Van Antwerpen P; Duez P
J Ethnopharmacol; 2014 Jun; 154(2):361-9. PubMed ID: 24746482
[TBL] [Abstract][Full Text] [Related]
17. Myeloperoxidase as a Target for the Treatment of Inflammatory Syndromes: Mechanisms and Structure Activity Relationships of Inhibitors.
Soubhye J; Aldib I; Delporte C; Prévost M; Dufrasne F; Antwerpen PV
Curr Med Chem; 2016; 23(35):3975-4008. PubMed ID: 27281130
[TBL] [Abstract][Full Text] [Related]
18. Discovery of a novel indole pharmacophore for the irreversible inhibition of myeloperoxidase (MPO).
Patnaik A; Axford L; Deng L; Cohick E; Ren X; Loi S; Kecman S; Hollis-Symynkywicz M; Harrison TJ; Papillon JPN; Dales N; Hamann LG; Lee L; Regard JB; Marcinkeviciene J; Marro ML; Patterson AW
Bioorg Med Chem; 2020 Jun; 28(12):115548. PubMed ID: 32503688
[TBL] [Abstract][Full Text] [Related]
19. Discovery of Novel Potent Reversible and Irreversible Myeloperoxidase Inhibitors Using Virtual Screening Procedure.
Soubhye J; Chikh Alard I; Aldib I; Prévost M; Gelbcke M; De Carvalho A; Furtmüller PG; Obinger C; Flemmig J; Tadrent S; Meyer F; Rousseau A; Nève J; Mathieu V; Zouaoui Boudjeltia K; Dufrasne F; Van Antwerpen P
J Med Chem; 2017 Aug; 60(15):6563-6586. PubMed ID: 28671460
[TBL] [Abstract][Full Text] [Related]
20. Ordered cleavage of myeloperoxidase ester bonds releases active site heme leading to inactivation of myeloperoxidase by benzoic acid hydrazide analogs.
Huang J; Smith F; Panizzi P
Arch Biochem Biophys; 2014 Apr; 548():74-85. PubMed ID: 24632143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
